The Impact of Long-Term Clinical Evidence on Cost-Effectiveness of Exenatide Once Weekly (Bydureon®) Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus (T2dm) From A Uk Nhs Perspective
Abstract
Authors
M. Charokopou H. Vioix B.G. Verheggen T. Bratt D. Franks